Fangzhou Inc. (6086.HK) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-28). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computed from published company financials, balance sheet as of 2025-12-31. 6086.HK files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 3.94% | 30.00% | Pass |
| Interest-bearing investments | 34.59% | 30.00% | Fail |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 8.30% | 33.00% | Pass |
| Interest-bearing investments | 38.64% | 33.00% | Fail |
| Non-liquid assets | 53.77% | at least 20.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.40% | 33.33% | Pass |
| Cash + interest-bearing securities | 38.64% | 33.33% | Fail |
| Accounts receivable | 46.23% | 33.33% | Fail |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 4.40% | 33.33% | Pass |
| Cash + interest-bearing securities | 38.64% | 33.33% | Fail |
| Accounts receivable | 46.23% | 50.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.85% | 33.00% | Pass |
| Cash + interest-bearing securities | 7.48% | 33.00% | Pass |
| Accounts receivable | 1.47% | 33.00% | Pass |
ℹ️ MSCI M-Series, S&P Shariah divide by a trailing-average market cap (24- or 36-month) rather than today's. That price history is not collected for non-US listings, so these are reported as unverified — it reflects a missing input on our side, not anything about the company.
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 51.10 | NEUTRAL |
| Stochastic %K (14) | 48.84 | NEUTRAL |
| CCI (20) | 53.72 | NEUTRAL |
| Williams %R (14) | -51.16 | NEUTRAL |
| MACD (12,26,9) | 0.01 | BUY |
| ROC (10) | 6.52 | BUY |
| Momentum (10) | 0.05 | BUY |
| EMA (10) | 0.74 | SELL |
| SMA (10) | 0.75 | SELL |
| EMA (20) | 0.73 | BUY |
| SMA (20) | 0.71 | BUY |
| EMA (30) | 0.73 | BUY |
| SMA (30) | 0.71 | BUY |
| EMA (50) | 0.77 | SELL |
| SMA (50) | 0.73 | BUY |
| EMA (100) | 1.00 | SELL |
| SMA (100) | 0.87 | SELL |
| EMA (200) | 1.73 | SELL |
| SMA (200) | 1.60 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Pharmaceutical Retailers
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory diseases. It also engages in the sales of pharmaceutical and healthcare products through online retail pharmacy service platform, third-party platforms, and offline retail pharmacies; and online consultation, e-prescription, physician consultation, physical examination, and surgery service, as well as wholesale of pharmaceutical products. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.